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Subtype C human immunodeficiency virus type 1 (HIV-1C) continues to cause the majority of new cases of
mother-to-child transmission (MTCT), and yet there are limited data on HIV-1C transmission. We amplified
env from plasma RNA for 19 HIV-1C MTCT pairs, 10 transmitting in utero (IU) and 9 transmitting intrapar-
tum (IP). There was a strong genetic bottleneck between all mother-infant pairs, with a majority of transmis-
sion events involving the transmission of a single virus. env genes of viruses transmitted to infants IP, but not
IU, encoded Env proteins that were shorter and had fewer putative N-linked glycosylation sites in the V1-V5
region than matched maternal sequences. Viruses pseudotyped with env clones representative of each maternal
and infant population were tested for neutralization sensitivity. The 50% inhibitory concentration of autolo-
gous serum was similar against both transmitted (infant) and nontransmitted (maternal) viruses in a paired
analysis. Mother and infant Env proteins were also similar in sensitivity to soluble CD4, to a panel of
monoclonal antibodies, and to heterologous HIV-1C sera. In addition, there was no difference in the breadth
or potency of neutralizing antibodies between sera from 50 nontransmitting and 23 IU and 23 IP transmitting
HIV-1C-infected women against four Env proteins from heterologous viruses. Thus, while a strong genetic
bottleneck was detected during MCTC, with viruses of shorter and fewer glycosylation sites in env present in
IP transmission, our data do not support this bottleneck being driven by selective resistance to antibodies.
The biological mechanisms involved in human immunodefi-
ciency virus type 1 (HIV-1) transmission remain largely un-
clear. A genetic bottleneck has been routinely observed in both
horizontal and vertical transmission, although findings on char-
acteristics of these transmitted viruses are conflicting and may
depend on the mode of transmission or subtype of the infecting
virus. Owing to the availability of matched donor-recipient
pairs and the relatively well-defined timing of transmission,
mother-to-child transmission (MTCT) of HIV-1 is a tractable
setting in which to study this bottleneck and determine the
viral characteristics and/or immune responses associated with
transmission, with the potential to suggest mechanisms.
Correlations between HIV-1 transmission, variable loop
length and number of putative N-linked glycosylation (PNG)
sites encoded in the HIV env gene have been reported in some
studies (9, 10, 33, 58, 59, 60) but not in others (9, 32, 47). In
horizontal transmission, acutely infected subjects were found
to have shorter variable loops and fewer PNG sites encoded in
env compared to subjects with chronic HIV-1 infection for
subtypes A and C, but not subtype B (10, 32, 34). In vertical
transmission, one study of an HIV-1 subtype CRF_AE-infected
cohort found no difference in sequence length or PNG
sites, while in other studies analyzing multiple subtypes there
were fewer PNG sites in transmitted viruses (47, 59). Shorter
variable loops and fewer PNG sites have separately been
shown to correlate with increased viral fitness (42) and greater
neutralizing antibody sensitivity (22). One study suggested
HIV-1C viruses newly transmitted from mother-to-child were
more fit, had significantly fewer PNG sites, and were more
resistant to autologous maternal serum than nontransmitted
viruses (60). For studies that analyzed vertical transmission
stratified by timing, viral populations have been reported to
have different properties if transmitted in utero (IU) or intra-
partum (IP) (3, 11, 30).
There is no consensus on the role neutralizing antibodies
may play in MTCT. Animal studies have demonstrated that
neutralizing antibodies elicited by a simian immunodeficiency
virus (SIV) vaccine can at least slow disease progression (56),
while direct administration of antibodies matched to the chal-
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lenge virus can block transmission (16, 44). Studies of natural
MCTC have yielded conflicting results (2, 3, 7, 20, 26, 31, 32,
48), although possibly for identifiable reasons. The breadth of
the neutralizing antibody response may depend on the subtype
of HIV-1 being studied (5, 10), and neutralizing antibody levels
may be associated with the timing of transmission (3). A compre-
hensive picture of the effect of neutralizing antibodies on MTCT
is difficult to obtain because of small sample sizes and different
subtypes and methods involved in the reports. Thus, larger studies
of relevant subtypes accounting for transmission timing are
needed to better understand the transmission mechanisms. There
is also uncertainty about the role of antibodies in superinfection
(6, 54).
In the present study we analyzed HIV-1 subtype C env genes
from 19 mother-infant pairs: 10 transmitting IU and 9 trans-
mitting IP. We confirmed the strong genetic bottleneck asso-
ciated with vertical transmission. Compared to the maternal
viral population, viruses transmitted IP tended to have shorter
variable loops and fewer PNG sites than viruses transmitted
IU. However, we also found that env pseudotyped viruses from
transmitted infant variants and maternal variants were not
significantly different in overall sensitivity to neutralization by
monoclonal antibodies or heterologous or autologous serum.
These data argue against a model in which the transmitted
virus is differentially sensitive or resistant to neutralization
compared to the mother’s virus population.
MATERIALS AND METHODS
Ethics statement. Plasma samples were collected as part of the Malaria and
HIV-1 in Pregnancy (MHP) prospective cohort (17, 29, 30, 38, 39). The MHP
study was approved by both the Malawi College of Medicine Research Commit-
tee and the Institutional Review Board at the University of North Carolina at
Chapel Hill. Informed, written consent was obtained for all participants.
Study participants. Women and their newborn infants were all documented to
have received single-dose nevirapine according to the HIVNET 012 protocol
(19). There was no association between malaria coinfection and HIV-1 trans-
mission in the MHP study (40), but women transmitting IU had higher rates of
syphilis coinfection than all other groups (39).
Plasma and serum were isolated from blood collected at labor-ward admission
from the women prior to nevirapine administration. Plasma was also stored from
the umbilical cord and infant heel-pricks at three time points: within 48 h of
birth, at 6 weeks of age, and at 12 weeks of age. HIV-1 transmission from mother
to infant was categorized by timing according to the method of Bryson et al. (8)
as follows: infants who were determined to be HIV-1 DNA negative by real-time
PCR (35) at 0 and 6 weeks were defined as nontransmitters, infants who were
HIV-1 DNA positive at birth were defined as IU infections; and infants who were
HIV-1 DNA negative at birth and DNA positive at 6 weeks were defined as IP
infections. Given this definition of IP transmission, infants could have been
infected late IU, IP, or during early breast-feeding. Based on the availability of
the plasma, the ability to obtain PCR products, and the confirmation of a
phylogenetic linkage of maternal and infant sequences, 10/35 IU and 9/39 IP
transmission pairs were included in the present study. Within these pairs, eight
IP and three IU pairs had additional plasma from their 12-week postpartum visit
available. A sample from 6 weeks was also available for one additional IU
transmission pair and was analyzed. Of these women, one who transmitted IU
(subject 1468) was infected with malaria, and one who transmitted IU (subject
1629) and two who transmitted IP (subjects 312 and 2038) were infected with
syphilis.
Single genome amplification. Viral RNA was isolated from 140 l of plasma
by using a QIAmp viral RNA minikit (Qiagen, Germantown, MD). When 140
l of plasma was available, the entire volume was used. We used the single-
genome amplification (SGA) protocol (14, 41, 51) as developed for the env gene
(46) and described for subtype C (1). Briefly, cDNA was generated by using
Superscript III reverse transcriptase and an oligo(dT) primer, followed by RNase
H treatment (Invitrogen, Carlsbad, CA). The env gene was amplified by nested
PCR from the dilution of cDNA that resulted in ca. 30% positive PCRs. These
conditions ensure that 80% of the amplifications are initiated with a single
template, and it eliminates artifactual PCR-mediated recombination, which has
been observed when PCR amplifications are initiated with multiple templates
(46). PCR products were directly sequenced. Double peaks in the chromato-
grams were considered evidence for the presence of multiple templates in the
reaction, and the sequences from these amplicons were discarded, as were
sequences with deletions larger than 100 nucleotides compared to the consensus
sequence of the individual.
Phylogenetic analysis. Sequences were manually edited using Seaview (15),
and the boundaries of the V1-V5 region were determined from the protein
alignment in the HIV Sequence Compendium 2009 (28). A neighbor-joining
tree, including sequences from all pairs, was constructed to confirm epidemio-
logical linkage between the pairs and the absence of cross-sample contamination
(see Fig. S1 in the supplemental material). Matched maternal and infant se-
quences were most closely related to each other. All sequences clustered with
HIV-1 subtype C (data not shown). Epidemiologically linked sequences were
aligned by using MAFFT version 5.8 according to the L-INS-i method (23). The
model of evolution was determined by FindModel (www.hiv.lanl.gov) for each
pair, with GTR plus gamma often being the best fit, and a maximum-likelihood
phylogenetic tree was constructed without gap-stripping using the Mobyle plat-
form for the PHYML program (21). Trees were resampled 100 times, and
bootstrap values greater than 70 were considered significant. Unrelated subtype
C outgroups were used to root each tree (data not shown for space).
We estimated the average evolutionary divergence within each sample using
the Kimura two-parameter method in MEGA4 (25, 55). The rate variation
among sites was modeled with a gamma distribution (shape parameter  0.5).
All positions containing alignment gaps and missing data were eliminated only in
pairwise sequence comparisons (pairwise deletion option) to retain the most data
for comparison.
Positive selection was assessed by using the Datamonkey webserver of the
HyPhy Package (43). Sequences from IP infant 1100 could not be analyzed
because of the absence of three unique sequences within the 15 amplicons.
Sequences that appeared to be from recombinants were excluded from the
analysis, and distinct lineages within an infant with more than three sequences
were analyzed separately. Codon-optimized alignments were created with
HIValign (http://www.hiv.lanl.gov) and uploaded to the Datamonkey server.
Evolutionary models were chosen by the automatic model selection tool (most
alignments fit the F81 model) and then analyzed by the Parris method (49) for
an overall test of selection. There was not enough diversity in the infant se-
quences for an accurate measure by codon-specific selection analysis.
Evidence of recombination was initially identified by using the Highlighter tool
and visual inspection. Where recombination was suspected, the single breakpoint
recombination (SBP) tool on the Datamonkey webserver was used to confirm
recombination, and the genetic algorithms for recombination detection (GARD)
tool was used to identify breakpoints (27). Sequences from longitudinal infant
time points were analyzed together when available.
Pseudotyped virus. env genes amplified with the upstream primer EnvA*
(CACCGGCTTAGGCATCTCCTATGGCAGGAAGAA) and the downstream
primer EnvN (CTGCCAATCAGGGAAGTAGCCTTGTGT) were cloned into
the pcDNA3.1 vector (Invitrogen). env amplicons for cloning were chosen to
represent the diversity of each viral population, assessed using the maximum-
likelihood phylogenetic trees described above. Pseudotyped virus stocks were
made according to previously published protocols (37) for each env gene clone,
as well as with plasmids containing SF162, TV-1, MW965, and JRCSF env genes.
MW965 encodes a highly neutralization-sensitive subtype C Env protein (40, 50),
while JRCSF encodes an Env protein that is subtype B and only moderately
neutralization sensitive. The env expression plasmid and env pNLCH backbone
(a derivative of pNL4-3) plus luciferase (J. Jeffries, unpublished data) were
cotransfected into 293T cells using the FuGENE 6 transfection reagent (Roche
Applied Science, Indianapolis, IN). The supernatants were harvested after 48 h.
Serum and monoclonal antibodies. Maternal serum was available from the
hospital admission for testing autologous neutralization sensitivity. Soluble CD4
(R&D Systems, Minneapolis, MN), a panel of broadly neutralizing monoclonal
antibodies (IgG1b12, 2G12, 2F5, and 4E10), and heterologous sera (HIVIG,
BB8, BB28, BB47, and BB68) from HIV subtype C-infected individuals (18)
were also used to test general neutralization sensitivity of the Env proteins.
Viruses pseudotyped with SF162, TV-1, MW965.26, and JRCSF were used to
test heterologous neutralizing antibody activity in maternal sera. All available
serum samples from transmitting mothers were used (at least 23 IU and 23 IP;
more were used for some env genes, but there was not sufficient volume of all
sera to test all four Env proteins), while serum samples from twice the number
of the transmitting group (n  50) were used from the nontransmitting group of
mothers.
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Neutralizing antibody assay. Single-round neutralizing antibody assays were
performed as described previously (37). Neutralization was quantified by a re-
duction in luciferase reporter gene expression after infection of TZM-bl cells
(NIH AIDS Research and Reference Reagent program catalog no. 8129). Titers
were reported as the antibody concentration or reciprocal serum dilution with a
50% reduction in relative luminescence units. Values were interpolated by using
five-parameter curve fitting.
Glycosylation site comparison. Sequences were translated by using the Trans-
late program (www.hiv.lanl.gov) and aligned with MAFFT version 5.8 using the
L-INS-i method (23); putative glycosylation sites were identified by using the
N-Glycosite tool (61). The fraction of maternal sequences with each glycosyl-
ation site was subtracted from the fraction of infant sequences with that same site
to calculate the fractional difference between mothers and infants. Some vari-
ability in the location of each glycosylation site was allowed, particularly within
the variable regions (i.e., if each sequence from a subject had a single PNG site
within a 2- to 3-amino-acid range of the alignment, this was considered an
equivalent site for the calculation).
Statistical methods. Differences in average sequence length and the number of
glycosylation sites between transmission pairs were calculated both overall and
within strata defined by transmission route, using linear generalized estimating
equations (GEE; SAS 9.2; SAS, Inc., Cary, NC), with standard errors (SE) calcu-
lated using robust variance estimators (based on exchangeable correlation matrices).
GEE estimates were calculated using the putative transmitted variants (n  25
sequences) only. To confirm model-based results, a resampling-based approach was
also used both to calculate transmission pair differences and to account for clustering
between pairs. Here, mean PNG or mean nucleotide length was first calculated for
each cluster of maternal sequences. Each maternal cluster was then sampled 10,000
times with replacements, and the differences between the cluster mean and the
sampled observation were calculated. These differences were summed across ma-
ternal clusters, resulting in a normal distribution of summed differences centered at
zero. For both mean PNG and nucleotide length, the corresponding transmitted
variant value for each paired infant was subtracted from the maternal mean,
summed across pairs, and compared to the 95% confidence intervals of the boot-
strapped maternal distribution overall and for IP and IU pairs separately.
Differences in the average 50% titers between maternal and infant clones were
compared by using a Wilcoxon signed-rank test (STATA 8.2; STATA, College
Station, TX). In addition, for a regression-based analysis (SAS 9.2), the distri-
butions of 50% inhibitory titers were examined to determine the variability
between pairs and the overall sampling distribution. Ultimately, values were
categorized by using the median number of micrograms added (monoclonal
antibodies) or a 1/dilution (polyclonal antibodies) for 50% inhibition of infec-
tivity as cutoff points, since this allowed us to examine the relationship between
mother and infant clones for the broadest panel of antibodies (59). Using these
binary variables, we modeled the probability of increased resistance to neutral-
ization using GEE-based logistic regression with exchangeable correlation ma-
trices to estimate odds ratios and 95% confidence intervals comparing resistance
among mother versus infant clones, both overall and by the timing of the HIV
transmission. Thus, odds ratios that contrast maternal and infant clones 1 are
associated with increased resistance to neutralization for maternal clones, whereas
odds ratios 1 are associated with decreased resistance to neutralization.
As a sensitivity analysis to confirm that sequences from our small sample of
mothers were similar to those from other chronically infected individuals, we com-
pared IU and IP maternal sequences to a large data set of sequences from subjects
chronically infected with subtype C HIV-1 (1,000 sequences; from 69 subjects with
approximately 20 sequences per subject [L. Ping et al., unpublished data]). For each
population, we sampled 10 sequences with replacements, calculated a mean for each
population (maternal or other chronic) and variance, and then calculated a differ-
ence in means and variance between each population. This was repeated 10,000
times for each parameter (nucleotide length and PNG site number) to obtain a
bootstrapped SE estimate around the difference in means used to calculate 95%
confidence intervals. All estimates were calculated using SAS version 9.2.
Standard statistical tests were performed with Prism 4 for Macintosh (version
4.0a). Correlations between number of glycosylation sites and loop length were
tested by using a two-tailed Pearson coefficient model. Differences in median
titers of serum from nontransmitting and IU- and IP-transmitting participants to
SF162, TV-1, MW965, and JRCSF pseudoviruses were assessed by using the
Kruskal-Wallis test.
Nucleotide sequence accession numbers. The sequences were submitted to
GenBank under accession numbers JN108036 through JN108760.
RESULTS
Subject characteristics. We used single-genome amplifica-
tion to amplify the entire env gene (2,600 bp) and sequenced
the V1-V5 region from HIV-1 viral genomes isolated from
plasma for 19 MTCT pairs. Ten infants were HIV positive at
birth and classified as being infected IU, and nine infants were
HIV negative at birth but positive at 6 weeks and were classi-
fied as being infected IP. We generated a median of 15 env
gene amplicons per subject (range, 4 to 24). The characteristics
of these mother-infant pairs are shown in Table 1.

























1468 4.6 274 IU 13 5.7 (0.9) 17 0.0 (0) 14 0.2 (0.2)
1551 4.7 360 IU 13 7.8 (1.1) 12 0.4 (0.2) 16 2.5 (0.5)
1585 4.4 529 IU 9 0.70 (0.3) 14 0.1 (0.1) ND ND
1629 4.8 342 IU 17 5.4 (0.9) 19 0.2 (0.1) ND ND
1851 NDb 761 IU 14 3.2 (0.9) 16 1.2 (0.4) ND ND
2199 3.8 476 IU 4 1.8 (0.4) 15 0.1 (0.1) 12 0.1 (0.1)
2444 4.8 511 IU 18 4.8 (0.8) 11 0.3 (0.2) 16c 0.1 (0.1)
2570 ND 65 IU 15 5.0 (0.9) 12 1.1 (0.3) ND ND
2797 ND 399 IU 19 9.4 (1.6) 21 0.2 (0.1) ND ND
3321 ND 220 IU 9 6.2 (1.1) 11 0.3 (0.2) ND ND
312 5.3 180 IP 18 7.3 (1.4) 18 0.7 (0.3) 14 1.0 (0.3)
819 4.4 891 IP 5 3.3 (0.9) 16 1.1 (0.3) 23 2.3 (0.7)
874 4.9 228 IP 9 4.5 (0.007) 16 0.1 (0.1) 15 0.5 (0.2)
1100 5.4 127 IP 16 12 (1.6) 16 0 (0) ND ND
1846 5.7 44 IP 19 1.8 (0.4) 24 0 (0) 12 1.8 (0.4)
1945 5.5 157 IP 14 3.6 (0.7) 19 0.2 (0.1) 17 0 (0)
2038 4.4 156 IP 8 7.1 (1.3) 21 4.4 (0.9) 23 0.1 (0.1)
2684 4.7 122 IP 15 6.3 (1.0) 14 0.5 (0.2) 11 1.2 (0.3)
2909 5.3 1,092 IP 19 5.0 (0.9) 12 0 (0) 21 1.2 (0.3)
a Calculated with MEGA 4.1 0.5 gamma distribution.
b ND, no data.
c Six-week sample.
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Complexity of transmitted virus in vertical transmission.
Using pairwise diversity comparisons, we quantified the ge-
netic bottleneck between maternal and infant viral populations
and found a significant reduction in diversity (P  0.0001)
(Table 1); representative phylogenetic trees are shown in Fig.
1. Using both the diversity calculations and the phylogenetic
trees, we determined that viral populations in 80% of the
infants infected IU (8 of 10) and 56% of the infants infected IP
(5 of 9) were homogeneous (defined here as 0.4% diversity
with negligible branching in trees) and represented infection
seeded by a single variant (see Fig. 1A and B for examples).
We define the “transmitted variant” as the variant(s) that
passed from mother to child and replicated in the infant to a
level detectable by our sequence sampling methods. Additional
variants may have passed into the recipients but failed to es-
tablish an infection. It should also be noted that all women
received single-dose nevirapine, which could have reduced the
number of variants circulating in women during IP transmis-
sion, thus possibly masking an even greater difference in the
proportion of multiple-variant transmissions. Based on this
analysis we conclude that a single variant initiated the observed
viral population in most of the IU and more than 50% of the
IP transmission events.
The remaining six infants (two IU and four IP) were infected
with multiple maternal variants. In two IU-infected (infants
1851 and 2570) and one IP-infected (infant 2038) infants, vari-
ants segregated to two distinct branches in the phylogenetic
trees, indicating the transmission of multiple variants (Fig. 1C
and D). For three additional IP pairs (infants 312, 2684, and
819), there was significant branching and low bootstrap values
for nodes including infant sequences, a finding consistent with
the transmission of multiple variants. Visual inspection of the
alignments using the Los Alamos Highlighter tool (http://www
.hiv.lanl.gov) suggested recombination of the major variant
with an undetected transmitted variant. Recombination was
supported by the Datamonkey SBP tool in all three alignments,
and breakpoints were identified by GARD in the sequences
from infants 312 and 819 (27). The absence of detection of the
putative second parent is likely due to limited sampling of the
infant viral populations. This interpretation is supported by
longitudinal sequences from infant 312, where the second par-
ent of a recombined sequence at 6 weeks was detected at 12
weeks (Fig. 1E, the lineage marked with a star; see also Fig. S4
in the supplemental material). Although this could represent a
second transmission event, given the diversity in the maternal
sequences and the probability that variants of 20% abun-
dance could be missed in our sampling, an increase in abun-
dance over time in the infant seems more likely than the
transmission of the matching parent sequence by chance. Thus,
phylogenetic trees and recombination analysis provide evi-
dence for multiple variants transmitted in 2 of 10 IU and 4 of
9 IP MTCT pairs.
Features of transmitted env sequence. We next examined
Env protein characteristics encoded in the env gene sequence.
We stratified the mother-infant pairs according to the timing of
the infant HIV-1 infection and analyzed the differences in
average sequence length with a GEE model. In this analysis a
single sequence was used for each transmitted virus. Infant env
sequences were on average significantly shorter than matched
maternal env sequences for IP transmission pairs (P  0.008),
with statistical support also obtained for a shorter V1-V2 do-
main (P  0.012). Although the infant env sequences of the IU
transmission pairs were often different in length from the ma-
ternal sequences, they were not consistently longer or shorter
(P  0.11). We also compared the most abundant transmitted
infant env sequence to the matched maternal population using
a resampling approach. IP infant env sequences tended to be
shorter than maternal env sequences but fell outside the resa-
mpling distribution only for the C3-V4 region (Fig. 2A). IU
infant sequences tended to be longer but were within the 95th
percentile resampling range (Fig. 2A). For this data set we also
noted that the mean length of the maternal env sequences of
mothers who transmitted IP was longer than the mean from
IU-transmitting mothers (mean, 1,013 versus 1,010 nucleo-
tides, respectively). In order to exclude the possibility that the
IP mothers included in the present study represented a biased
sample, we compared the average env length of the mothers
who transmitted IU and IP against a random selection of
HIV-1 subtype C env genes. Neither the IU nor the IP mean
maternal env sequence length was statistically different from
either the randomly selected chronic subtype C samples or
each other (P  0.6, 0.4, and 0.7, respectively). We previously
noted in this cohort that the mothers who transmitted IP were
more likely to have lower CD4 cell counts compared to the
mothers who transmitted IU (30), but we found no correlation
between CD4 count and maternal env sequence length (data
not shown). Therefore, we conclude that the mean length of
the env V1-V5 region of the transmitted variant is on average
shorter than the mean of the maternal env population for IP
but not for IU transmissions.
We next analyzed the number of encoded PNG sites in each
sequence, as identified using the N-Glycosite program (61).
Using the GEE model, we found the mean number of PNG
sites in V1-V5 in IP infant env sequences was significantly less
than matched maternal env sequences (P  0.012), and the
effect was most pronounced in V1-V2 (P  0.006). No differ-
ence was seen in IU pairs. We also analyzed this difference
using the resampling approach, and again IP-transmitted se-
quences encoded fewer glycosylation sites than the maternal
sequences (Fig. 2B), with both the V1-V2 and the V4 variable
regions contributing to this effect. In the IU-transmitted se-
quences there was variation in the encoded glycosylation sites
between maternal and infant env genes, fewer in V1-V2 and
greater in C3-V4 (Fig. 2B), but not a significant difference in
number of total N-linked glycosylation sites. Thus, there ap-
pears to be selection for viruses with fewer glycosylation sites
in infants infected by IP, but not IU, transmission.
Early env gene sequence evolution in the infant. Twelve-
week longitudinal samples were available for 8 of 9 IP-infected
infants and for 3 of 10 IU-infected infants; an available 6-week
sample for IU-infected infant 2444 was also analyzed. Se-
quences from these samples were compared to sequences from
the first positive sample to examine early changes within each
transmitted infant population.
There was statistical evidence of positive selection even with
the sparse amount of sequence evolution that occurred over
this time period in two of the IP-infected infants (infants 819
and 2909) and one IU-infected infant (infants 1551) (data not
shown). Additional infants had a small number of fixed muta-
tions that, while statistically insignificant, suggest selection,
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FIG. 1. Representative maximum-likelihood phylogenetic trees of sequences from the V1-V5 region of env. Pink circles denote maternal
sequences, blue squares denote the first-positive infant sequences, and green diamonds denote infant sequences at 12 weeks for transmission pairs
1468 (A), 3321 (B), 8151 (C), 2038 (D), and 312 (E) (a star marks the putative second parent of recombined sequences). M-X (maternal), B-X
(infant at birth), and 6wk-X (infant at 6 weeks) env genes were cloned, and the data for sensitivity to neutralizing antibody of the pseudotyped virus
are found in Tables S1 and S2 in the supplemental material. Branches containing unrelated outgroups were deleted for space.
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with the majority of fixed mutations found in C3-V4. Further-
more, in one IU-infected (infant 1551) and five IP-infected
(infants 312, 874, 1846, 2684, and 2909) infant sequences there
were clustered mutations or different nonsynonymous muta-
tions at a single amino acid codon and/or glycosylation site (see
the Highlighter plot in Fig. S3 in the supplemental material).
These types of mutations are consistent with the types of pat-
terns seen with CTL escape or for a replication advantage
associated with the loss of a glycosylation site.
In three infants (infants 1551, 2038, and 2909) we observed
changes in abundance of variants within a population from
selective outgrowth, a possible second transmission event
through breast-feeding, or both. Because a second transmis-
sion event is statistically unlikely, these shifts imply a changing
selective advantage during early infection, whether in relative
fitness or escape from developing immune pressure.
Sensitivity of transmitted and maternal Env proteins to
neutralization by heterologous antibodies. We tested full-
length env clones from each maternal and infant sample to
determine whether transmitted viruses had different sensitivi-
ties to neutralizing monoclonal antibodies and heterologous
neutralizing antibodies compared to nontransmitted maternal
variants. This was done for the 10 IU and 6 IP transmission
pairs with stored maternal serum available. Pseudotypes were
made with cloned env genes that represented the diversity of
the maternal viral population (based on phylogenetic tree to-
pology [Fig. 1 and see Fig. S2 and S3 in the supplemental
material]; n  50 clones in total) and infant/transmitted se-
quences, including multiple variants when more than one vari-
ant was transmitted (n  20).
Consistent with previous studies of subtype C primary iso-
lates (4, 32), the pseudotyped viruses displayed some sensitivity
to 4E10 and soluble CD4 but were resistant to 2G12, 2F5, and
IgG1b12. There were no significant differences in neutralizing
antibody titers between transmitted and nontransmitted vari-
ants (analyses summarized in Table 2). Stratified by timing,
however, variants transmitted IU tended to have increased
resistance to 4E10 compared to the values for the average of
the maternal Env proteins (Table 2), however driven by only a
subset of cases (see Table S1 in the supplemental material).
The sensitivity to heterologous subtype B and C sera was
also tested. In most cases, the transmitted/infant env clone was
similarly sensitive to the range of values obtained with viruses
generated with the maternal env clones, and there was no
pattern of higher or lower sensitivity when considering the
absolute titer (Table 2).
Sensitivity of transmitted and maternal Env proteins to
autologous antibodies. We next compared the sensitivity to
neutralization by concurrent maternal antibodies. Due to lim-
ited available serum volume not all clones could be tested. As
shown in Tables S1 and S2 in the supplemental material, all of
the transmitted pseudotyped viruses demonstrated sensitivity
FIG. 2. Infant sequence characteristics compared to resampling distribution of each maternal population. The bar represents the 95%
confidence interval of the summed differences for each maternal population between 10,000 random resamples of each population and the actual
mean for nucleotide length (A) and the number of putative N-linked glycosylation sites (B). Diamonds and squares indicate summed differences
between infant and source maternal populations.
TABLE 2. Signed-rank z-scores comparing 50% neutralization
sensitivities between paired maternal and infant clonesa
Serum
Signed-rank z-score
All pairs IU IP
sCD4 1.50 1.17 0.73
4E10 1.71 2.19 0.31
HIVIG 0.49 1.84 0.94
BB8 1.24 0.15 2.11
BB28 1.03 2.09 0.73
BB47 0.72 1.48 0.31
BB68 0.23 0.76 1.94
Autol 0.97 0.89 0.52
a A z-score of 1.96 indicates two-tailed significance at P  0.05. A positive
z-score indicates that the infant sequences were more resistant to neutralization.
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to maternal serum, and at least one maternal clone from each
woman was sensitive to neutralization. However, there was no
consistent pattern of difference within pairs overall or when
stratified by transmission status (Table 2, Autol). Thus, in this
data set we found no evidence for selection of a neutralization
sensitive or resistance variant during vertical transmission.
Neither the number of PNG sites nor the loop length was
significantly associated with neutralization sensitivity. Longer
loop length was associated with greater resistance to neutral-
ization by the monoclonal antibody 4E10 over the whole
V1-V5 region (P  0.006 [data not shown]), though with only
R2  0.11. gp41 was not sequenced; thus, we could not examine
potential linked changes in the 4E10 epitope, although other
regions or structures can impact epitope recognition (13).
Maternal heterologous neutralizing antibody titers. We also
tested maternal sera available from additional study partici-
pants who transmitted IU (n  23) and IP (n  23), along with
a subset of nontransmitting women (n  50), for neutralizing
antibody activity against viruses pseudotyped with heterolo-
gous subtype C and B Env proteins. Median neutralizing an-
tibody titers were similar in sera from the three groups of
women to all Envs (Fig. 3). We compared NT, IU, and IP
women by the number of participants with an IC50 of 40 or
greater to multiple pseudotyped viruses using a chi-squared
analysis to assess breadth, and there were no differences be-
tween the groups. Thus, we did not find a difference in neu-
tralization activity or breadth of response to heterologous Env
proteins between transmitting and nontransmitting maternal
sera.
DISCUSSION
The characteristics and mechanisms of MTCT of HIV-1 are
conflicting in the current literature, with no studies to date
obtaining a full analysis of the genetic sequence, susceptibility
of transmitted and nontransmitted virus to antibody neutral-
ization, and breadth and potency of maternal serum all within
the same cohort. We analyzed these properties of HIV-1 sub-
type C transmission using 10 pairs with IU MTCT and nine
pairs with IP MTCT.
In our previous study using samples from this cohort, we
examined the diversity of env V1-V2 using the heteroduplex
tracking assay in 25 IU and 23 IP mother-infant pairs, as well
as 32 nontransmitting women. We concluded that on average
fewer variants are transmitted to infants infected IU than IP
(30). In the three infants (infants 819, 2038, and 2684) previ-
ously reported with two variants at an abundance detectable by
our level of SGA sampling (20%), the current analysis
showed a heterogeneous infant population.
A severe genetic bottleneck during transmission was con-
firmed in all pairs and, in a majority of transmission cases, the
infants harbored a single viral variant. We also found evidence
for the transmission of multiple viral variants in 2 of 10 IU-
infected infants and 4 of 9 IP-infected infants, 6 of 19 overall.
Previous studies of MTCT, using similar methods, found a
heterogeneous infant viral population in 7 of 13 infants in-
fected with subtype CRF01_AE (4 of 6 infected IU and 3 of 7
infected IP) and in 3 of 17 infants infected with subtype A
(unknown transmission timing) (47, 57). Thus, our data for
subtype C HIV-1 transmission are in line with previous studies
of other subtypes in the frequency of multiple-variant trans-
mission in MTCT, and overall with the conclusion that in a
majority of cases the infant is infected with a single variant.
HIV-1 subtype C transmitted IP had shorter variable loops
and fewer PNG sites than the maternal populations, but no
overall difference was seen in viruses transmitted IU. Previous
work by Samleerat et al. found no differences in these charac-
teristics in 11 IP pairs or 6 IU pairs infected with subtype
CRF01_AE (47). However, Wu et al. and Zhang et al. re-
ported fewer PNG sites in mostly IP-transmitted subtype A
and C viruses, respectively, and an association between num-
ber of PNG sites and variable loop length (59, 60). Our detec-
tion of viruses with fewer glycosylation sites in infants infected
IP is also consistent with the detection of underglycosylated
viruses in heterosexual transmission (9, 10, 32, 34) (Ping et al.,
unpublished). Fully glycosylated virus could be selected by
some mechanism within the placental environment, may not
replicate as rapidly in the new host (60), or may not be trans-
mitted as efficiently as underglycosylated virus via a mucosal
route. This also suggests IP may be more similar in mechanism
than IU to heterosexual transmission.
We previously found IP, but not IU, transmission was asso-
ciated with the disruption of the placental barrier (29). A priori,
mixing of maternal and infant blood suggests random exposure
to maternal blood variants. Although the number of variants
transmitted IP does trend higher (30) (Table 1), if extensive
FIG. 3. Heterologous neutralizing antibody titers of maternal sera
by transmission status: NT, nontransmitting; IU, in utero transmission;
IP, intrapartum transmission. The 50% neutralization titer was calcu-
lated against virus pseudotyped with env genes: SF162 (subtype B) (A),
TV-1 (subtype C) (B), MW965 (subtype C) (C), and JRCSF (subtype
B) (D). The lines represent the mean 50% inhibitory concentration
(IC50).
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mixing of maternal and infant blood was common the trans-
mission rates would likely be higher.
We saw evidence for early sequence evolution in the infant.
Replication after sexual transmission revealed the stochastic
incorporation of neutral mutations within the viral population
(24). Beyond these stochastic sequence changes we were able
to detect mutations becoming fixed and also examples of clus-
tered mutations. This suggests ongoing selective pressure pos-
sibly to repair fortuitously fixed deleterious mutations by re-
version or with compensatory mutations or to select for certain
replication properties in the new environment. We also ob-
served evidence for recombination, which requires dually in-
fected cells and is plausible given the high viral loads in in-
fected infants (51). These features of early sequence evolution
are consistent with the known features of HIV replication after
transmission.
Neutralizing antibodies are of intense interest for their po-
tential role in blocking transmission. It has been reported that
in heterosexual transmission the transmitted variant is more
neutralization sensitive to autologous antibodies than other
donor viral Env proteins (10). Autologous antibodies passed
during pregnancy and in breast milk could have two effects:
neutralizing antibodies in the mother could potentially block
viruses from passing to the infant, or the presence of neutral-
izing antibodies in the infant could select for viruses that were
especially resistant to neutralization from among the viral pop-
ulation in the mother.
In comparing the breadth and potency of serum for heter-
ologous neutralizing antibodies from transmitting mothers to
nontransmitting mothers, we found no difference in titers to
any of the four Env proteins tested, nor did we see evidence for
the serum of nontransmitting mothers to have greater breadth
of activity to these Env proteins than the transmitting mothers.
Although this is in contrast to previous results in subtype B-
infected women (12), a recent study has yielded results similar
to ours in that the neutralization breadth of maternal antibod-
ies measured in infant samples did not correlate with protec-
tion from infection (36). Higher breadth of maternal neutral-
izing antibodies, at least for women infected with non-B
subtypes, has thus shown no correlation with protection from
MTCT.
Autologous neutralizing antibodies would seem to have the
greatest potential to impact transmission, given that they are
against the very viral population the infant could be exposed
to. In a chronically infected individual, virus is generally resis-
tant to the contemporaneous autologous antibodies, i.e., the
host is always catching up to the rapidly escaping virus (45).
This may not be true for all replicating virus, however, since
studies report autologous neutralizing activity in at least 50%
of chronically infected women with multiple subtypes (59) and
up to 100% of women infected with subtype C (60) (see Tables
S1 and S2 in the supplemental material).
One could hypothesize that the transmitted/founder viruses
will be escape variants, resistant to any autologous neutralizing
activity. It has been reported that a virus that grew out in the
presence of maternal antibodies in cell culture was more sim-
ilar to the transmitted infant virus than the bulk maternal
population, interpreted to indicate that a neutralization escape
variant was transmitted (12). In that study, many of the infant
isolates that could not be neutralized by maternal serum came
from mothers who lacked autologous neutralizing antibodies,
likely providing a second test of the lack of maternal neutral-
izing antibodies rather than testing the relative sensitivity of
the transmitted virus. In cases where both maternal and infant
isolates could be neutralized by the maternal serum, the rela-
tive neutralization titers were not reported to be significantly
different. Also, the potential for PCR-mediated recombination
makes the reported genetic relationship uncertain (46). Other
studies have also reported that the transmitted variant is neu-
tralization resistant relative to the mother’s viral population
(59, 60). Although these studies took approaches similar to
that used in the present study, there are significant differences.
Even though in most cases the complexity of the transmitted
virus was consistent with a single variant being transmitted,
several clones were generated and analyzed from each infant
sample; however, since they were all derived from a single
transmitted virus, they cannot be considered independent ob-
servations for the purpose of analysis. In addition, viral se-
quences from the mother were generated from peripheral
blood mononuclear cell (PBMC) DNA. Discordance in drug
resistance markers and env sequences (52, 53) demonstrates
the overall turnover of viral sequences in PBMC DNA to be
slower than in the replicating viral RNA population. Given the
sequential nature of neutralization escape that has been seen
in the blood (45), one might observe a difference in neutral-
ization sensitivity to concurrent antibodies in viral sequences
derived from PBMC simply because of the difference in the
rates of turnover in these different compartments. In contrast,
when we compared the neutralization sensitivity of viral se-
quences present as RNA in maternal blood plasma to the
transmitted infant sequence, we found no statistically signifi-
cant difference in neutralization sensitivity to the autologous
maternal antibodies (Table 2). Thus, the transmitted virus is
characterized as having neutralization properties similar to
those of the replicating maternal viral sequences.
In summary, we found that in this cohort, a single variant of
HIV-1 subtype C was detected most often in infants after
MTCT, although examples of multiple-variant transmission
were also detected. We also found that on average viruses with
shorter sequence lengths in env and fewer encoded glycosyl-
ation sites in V1-V5 compared to the matched maternal se-
quences were transmitted to infants infected IP, but not IU.
Neutralization sensitivity to autologous maternal serum did
not differ in a statistically significant way when comparing
maternal and infant viruses, nor did sensitivity to a broad panel
of monoclonal antibodies or heterologous sera. In conclusion,
we did not find evidence that the transmitted virus in vertical
transmission is selectively resistant to maternal antibodies
compared to the contemporaneous maternal viral population,
nor is the transmitted variant distinctly sensitive or resistant to
heterologous antibodies.
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